23andMe (Venture Funded Company)

0:02:09

23andMe CEO Wojcicki: How the FDA changed our business | Fortune MPW

0:08:46

What Happened To 23andMe?

0:02:59

Behind 23andMe’s Venture into Drug Development | Fortune

0:01:35

23andme - Google's first Investment in Life Sciences!

0:14:08

Why 23andMe Failed

0:02:52

23AndMe CEO on How Consumers Can Change Healthcare | in-person | J.P. Morgan

0:00:36

Children Forced Me To Scale 🚸 #shorts

0:10:50

Partnering and The Future of 23andMe | Emily Dabrant Conley

0:57:10

The Future of Genetics in Our Everyday Lives (Full Session) | Interactive 2014 | SXSW

1:16:30

Genomes Unlocked: Anne Wojcicki's Vision for 23andMe and the Future of Proactive Healthcare | E1858

1:06:22

Anne Wojcicki On The Trials Of Building 23andMe And Leading A Company During The COVID Era

0:03:28

GlaxoSmithKline announces $300 million equity investment in 23andMe

0:04:24

What it Takes To Get Funding in Silicon Valley: Tips from Top Silicon Valley Investors

0:08:15

Building a Customer-First Company: Anne Wojcicki, 23andMe // Startup Elements

0:14:32

Anne Wojcicki on the FDA and future of 23andMe | Fortune

0:57:09

Anne Wojcicki, Co-founder and CEO of 23andMe

0:08:19

23andMe CEO Anne Wojcicki on Glaxo Partnership and Data Security

0:43:55

What We Can Learn From The Evolution Of 23andMe | Rock Health Summit 2018

0:52:53

Anne Wojcicki, CoFounder 23andMe, helps us access, understand & benefit from our DNA

1:02:05

Extra: Why Is 23andMe Going Under? (Update) | Freakonomics Radio

0:00:15

Genetics play a role in IBD

0:02:31

Healthcare is still ‘stuck in a world of white coats’: 23andMe CEO

0:15:03

23andMe: Inside the DNA revolution | Full Interview Fortune MPW

1:21:06

Linda Avey - The Co-Founder of 23andMe on the Next Phase of Consumer Genetic Testing